- You are viewing a Navigating Care library resource.
- Back to Library
To Learn More About Neuroblastoma
For more information from the National Cancer Institute about neuroblastoma, see:
- Neuroblastoma Home Page
- Neuroblastoma Screening
- Computed Tomography (CT) Scans and Cancer
- Drugs Approved for Neuroblastoma
- Targeted Therapy to Treat Cancer
- Immunotherapy to Treat Cancer
- New Approaches to Neuroblastoma Therapy (NANT)
For more childhood cancer information and other general cancer resources, visit:
- About Cancer
- Childhood Cancers
- CureSearch for Children's Cancer
- Late Effects of Treatment for Childhood Cancer
- Adolescents and Young Adults with Cancer
- Children with Cancer: A Guide for Parents
- Cancer in Children and Adolescents
- Staging
- Coping with Cancer
- Questions to Ask Your Doctor about Cancer
- For Survivors and Caregivers
This information is not intended to replace the advice of a doctor.
Navigating Care disclaims any liability for the decisions you make based on this information.
This information was sourced and adapted from Adapted from the National Cancer Institute's
Physician Data Query (PDQ®) Cancer Information Summaries on
www.cancer.gov.
This information updated
November 1, 2024.
Learn more:
- General Information About Neuroblastoma
- Stages of Neuroblastoma
- Treatment Option Overview
- Treatment of Low-Risk Neuroblastoma
- Treatment of Intermediate-Risk Neuroblastoma
- Treatment of High-Risk Neuroblastoma
- Treatment of Stage MS Neuroblastoma
- Treatment of Recurrent Neuroblastoma
- To Learn More About Neuroblastoma
Related Articles
- General Information About Neuroblastoma
- Stages of Neuroblastoma
- Treatment Option Overview
- Treatment of Low-Risk Neuroblastoma
- Treatment of Intermediate-Risk Neuroblastoma
- Treatment of High-Risk Neuroblastoma
- Treatment of Stage MS Neuroblastoma
- Treatment of Recurrent Neuroblastoma
- To Learn More About Neuroblastoma
More Resources
See Expert Resources
The Navigating Care Library includes articles about cancer, chemotherapy regimens and drugs from the
the National Cancer Institute and other experts.
